Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (361-370 of 542) with videos related to

Pageof 55
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Recurrent gram-negative bacteremia: incidence and clinical patternsC Wendt, S A Messer, R J Hollis, et al.
Journal of Clinical Microbiology|July 1, 1991
Comparison of the autoSCAN-W/A rapid bacterial identification system and the Vitek AutoMicrobic system for identification of gram-negative bacilliM A Pfaller, D Sahm, C O'Hara, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactamM A Pfaller, A L Barry, P C Fuchs, et al.
Journal of Clinical Microbiology|December 17, 2010
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilutionM A Pfaller, L Boyken, R J Hollis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 1999
Nosocomial bloodstream infections in United States hospitals: a three-year analysisM B Edmond, S E Wallace, D K McClish, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study GroupR N Jones, K C Kugler, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1993
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivativeW W Hoover, E H Gerlach, D J Hoban, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246R N Jones, J A Washington, M A Pfaller, et al.
Journal of Clinical Microbiology|August 7, 2009
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007M A Pfaller, S A Messer, R J Hollis, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of EnterobacteriaceaeP C Fuchs, A L Barry, M A Pfaller, et al.
Pageof 55

Showing results (361-370 of 542) with videos related to

Sort By:
Pageof 55
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 1999
Recurrent gram-negative bacteremia: incidence and clinical patternsC Wendt, S A Messer, R J Hollis, et al.
Journal of Clinical Microbiology|July 1, 1991
Comparison of the autoSCAN-W/A rapid bacterial identification system and the Vitek AutoMicrobic system for identification of gram-negative bacilliM A Pfaller, D Sahm, C O'Hara, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactamM A Pfaller, A L Barry, P C Fuchs, et al.
Journal of Clinical Microbiology|December 17, 2010
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilutionM A Pfaller, L Boyken, R J Hollis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 1999
Nosocomial bloodstream infections in United States hospitals: a three-year analysisM B Edmond, S E Wallace, D K McClish, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study GroupR N Jones, K C Kugler, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1993
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivativeW W Hoover, E H Gerlach, D J Hoban, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1991
Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246R N Jones, J A Washington, M A Pfaller, et al.
Journal of Clinical Microbiology|August 7, 2009
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007M A Pfaller, S A Messer, R J Hollis, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of EnterobacteriaceaeP C Fuchs, A L Barry, M A Pfaller, et al.
Pageof 55